BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29194596)

  • 1. Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-response.
    Reimer D; Boesch M; Wolf D; Marth C; Sopper S; Hatina J; Altevogt P; Parson W; Hackl H; Zeimet AG
    Int J Cancer; 2018 Apr; 142(8):1640-1651. PubMed ID: 29194596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VAV3 Overexpressed in Cancer Stem Cells Is a Poor Prognostic Indicator in Ovarian Cancer Patients.
    Kwon AY; Kim GI; Jeong JY; Song JY; Kwack KB; Lee C; Kang HY; Kim TH; Heo JH; An HJ
    Stem Cells Dev; 2015 Jul; 24(13):1521-35. PubMed ID: 25715123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (Iso-)form Matters: Differential Implication of Vav3 Variants in Ovarian Cancer.
    Boesch M; Reimer D; Sopper S; Wolf D; Zeimet AG
    Oncologist; 2018 Jul; 23(7):757-759. PubMed ID: 29674438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Vav3.1 as prognostic marker in endometrial cancer.
    Boesch M; Sopper S; Marth C; Fiegl H; Wiedemair A; Rössler J; Hatina J; Wolf D; Reimer D; Zeimet AG
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):2067-2076. PubMed ID: 30083818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of increased guanine nucleotide exchange factor Vav3 expression in human gastric cancer.
    Lin KY; Wang LH; Hseu YC; Fang CL; Yang HL; Kumar KJ; Tai C; Uen YH
    Mol Cancer Res; 2012 Jun; 10(6):750-9. PubMed ID: 22544459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Vav3 oncogene enhances the malignant potential of prostate cancer cells under chronic hypoxia.
    Hirai K; Nomura T; Yamasaki M; Inoue T; Narimatsu T; Chisato Nakada PD; Yoshiyuki Tsukamoto PD; Matsuura K; Sato F; Moriyama M; Mimata H
    Urol Oncol; 2014 Feb; 32(2):101-9. PubMed ID: 23403204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Expression of VAV Gene Family Predicts Poor Prognosis of Acute Myeloid Leukemia.
    Mu D; Long S; Guo L; Liu W
    Technol Cancer Res Treat; 2021; 20():15330338211065877. PubMed ID: 34894858
    [No Abstract]   [Full Text] [Related]  

  • 8. Major transcript variants of VAV3, a new member of the VAV family of guanine nucleotide exchange factors.
    Trenkle T; McClelland M; Adlkofer K; Welsh J
    Gene; 2000 Mar; 245(1):139-49. PubMed ID: 10713454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The guanine nucleotide exchange factor VAV3 participates in ERBB4-mediated cancer cell migration.
    Ojala VK; Knittle AM; Kirjalainen P; Merilahti JAM; Kortesoja M; Tvorogov D; Vaparanta K; Lin S; Kast J; Pulliainen AT; Kurppa KJ; Elenius K
    J Biol Chem; 2020 Aug; 295(33):11559-11571. PubMed ID: 32561640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vav3, a Rho GTPase guanine nucleotide exchange factor, increases during progression to androgen independence in prostate cancer cells and potentiates androgen receptor transcriptional activity.
    Lyons LS; Burnstein KL
    Mol Endocrinol; 2006 May; 20(5):1061-72. PubMed ID: 16384856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Gene Expression of the Proto-oncogene VAV3 and the Transcript Variant VAV3.1 in Oral Squamous Cell Carcinoma.
    Trenkle T; Hakim SG; Jacobsen HC; Sieg P
    Anticancer Res; 2015 May; 35(5):2593-600. PubMed ID: 25964534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of E2F family members in ovarian cancer--an evaluation in a training set of 77 patients.
    Reimer D; Sadr S; Wiedemair A; Stadlmann S; Concin N; Hofstetter G; Müller-Holzner E; Marth C; Zeimet AG
    Clin Cancer Res; 2007 Jan; 13(1):144-51. PubMed ID: 17200349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Vav3 protein and its prognostic value in patients with gastric cancer.
    Tan B; Li Y; Shi X; Fan L; Zhao Q; Liu Y; Tan M; Liu Q; Jia N
    Pathol Res Pract; 2017 May; 213(5):435-440. PubMed ID: 28285969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rho exchange factors vav2 and vav3 control a lung metastasis-specific transcriptional program in breast cancer cells.
    Citterio C; Menacho-Márquez M; García-Escudero R; Larive RM; Barreiro O; Sánchez-Madrid F; Paramio JM; Bustelo XR
    Sci Signal; 2012 Oct; 5(244):ra71. PubMed ID: 23033540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the characteristics of side population cells in the human ovarian cancer cell line OVCAR-3].
    Luo LJ; Zhao Z; Zeng JF; Liang B; Yang JX; Cao DY; Shen K
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):281-5. PubMed ID: 22781115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vav3 is linked to poor prognosis of pancreatic cancers and promotes the motility and invasiveness of pancreatic cancer cells.
    Tsuboi M; Taniuchi K; Furihata M; Naganuma S; Kimura M; Watanabe R; Shimizu T; Saito M; Dabanaka K; Hanazaki K; Saibara T
    Pancreatology; 2016; 16(5):905-16. PubMed ID: 27453460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer.
    Dong Z; Liu Y; Lu S; Wang A; Lee K; Wang LH; Revelo M; Lu S
    Mol Endocrinol; 2006 Oct; 20(10):2315-25. PubMed ID: 16762975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble isoforms but not the transmembrane form of coxsackie-adenovirus receptor are of clinical relevance in epithelial ovarian cancer.
    Reimer D; Steppan I; Wiedemair A; Concin N; Hofstetter G; Marth C; Müller-Holzner E; Zeimet AG
    Int J Cancer; 2007 Jun; 120(12):2568-75. PubMed ID: 17278108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vav3-rac1 signaling regulates prostate cancer metastasis with elevated Vav3 expression correlating with prostate cancer progression and posttreatment recurrence.
    Lin KT; Gong J; Li CF; Jang TH; Chen WL; Chen HJ; Wang LH
    Cancer Res; 2012 Jun; 72(12):3000-9. PubMed ID: 22659453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VAV3 regulates glioblastoma cell proliferation, migration, invasion and cancer stem‑like cell self‑renewal.
    Miao R; Huang D; Zhao K; Li Y; Zhang X; Cheng Y; Guo N
    Mol Med Rep; 2023 Apr; 27(4):. PubMed ID: 36960857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.